LRIT1: A Protein Involved in The Immune Response and Beyond (G26103)

Target Name: LRIT1

NCBI ID: G26103

LRIT1

Other Name(s): leucine-rich repeat, immunoglobulin-like and transmembrane domains 1 | Fibronectin type III, immunoglobulin and leucine rich repeat domains 9 | LRIT1_HUMAN | Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 1 | retina-specific protein PAL | PAL | FIGLER9 | Leucine rich repeat containing 21 | Leucine rich repeat, Ig-like and transmembrane domains 1 | Leucine-rich repeat-containing protein 21 | Retina-specific protein PAL | leucine-rich repeat-containing protein 21 | photoreceptor-associated LRR superfamily protein | leucine rich repeat, Ig-like and transmembrane domains 1 | LRRC21 | Photoreceptor-associated LRR superfamily protein | fibronectin type III, immunoglobulin and leucine rich repeat domains 9 | Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 1 precursor | leucine rich repeat containing 21

LRIT1: A Protein Involved in The Immune Response and Beyond

The immune system is a critical part of our bodies, and it is responsible for protecting our body from harmful pathogens and diseases. One of the key proteins that play a crucial role in the immune system is immunoglobulin-like (Ig) protein. These proteins are large, complex molecules that are made up of multiple domains, including transmembrane domains, cytoplasmic domains, and intrachellular domains. One of the most well-known proteins that contain these domains is LRIT1.

LRIT1 is a protein that is expressed in a wide range of tissues and cells in the body. It is characterized by the presence of three domains: a leucine-rich repeat, an immunoglobulin-like domain, and a transmembrane domain. The leucine-rich repeat is a common structural motif that is found in many proteins, including Ig proteins. The immunoglobulin-like domain is a region of the protein that contains the amino acids that are responsible for the protein's structural and functional properties. The transmembrane domain is a region of the protein that is responsible for the protein's ability to exist and function inside the cell membrane.

The LRIT1 protein is involved in a wide range of physiological processes in the body, including immune response, inflammation, and cell signaling. It is also a potential drug target, which means that scientists are studying the potential for using small molecules or antibodies to inhibit or activate LRIT1's activity.

The LRIT1 protein is involved in the immune response by providing a surface for the activation and recruitment of T cells. T cells are a critical part of the immune system, and they are responsible for cell-mediated immunity. LRIT1 is involved in this process by providing a surface for the T cell receptor (TCR), which is the protein that is responsible for recognizing and responding to foreign substances in the body.

In addition to its role in the immune response, LRIT1 is also involved in inflammation. It is a potent regulator of inflammation, and it is involved in the regulation of both acute and chronic inflammation. LRIT1 is able to inhibit the production of pro-inflammatory cytokines, such as interleukin-1 (IL-1), by regulating the activity of genes that are involved in this process.

LRIT1 is also involved in cell signaling, specifically in the regulation of cell adhesion. It is a protein that is involved in the formation of tight junctions, which are the gaps that form between cells and are involved in the exchange of nutrients and other substances between cells. LRIT1 is also involved in the regulation of cell-cell adhesion, which is the process by which cells stick together and form tissues.

The LRIT1 protein is also involved in the regulation of cell survival. It is a protein that is involved in the regulation of cell proliferation, and it is able to inhibit the production of pro-apoptotic proteins that can cause cells to die. This is important for the regulation of cell growth and the maintenance of tissue homeostasis.

In conclusion, LRIT1 is a protein that is involved in a wide range of physiological processes in the body. It is a potential drug target, and scientists are studying the potential for using small molecules or antibodies to inhibit or activate LRIT1's activity. Further research is needed to fully understand the role of LRIT1 in the immune system and its potential as a drug target.

Protein Name: Leucine Rich Repeat, Ig-like And Transmembrane Domains 1

Functions: Possible role in phototransduction

The "LRIT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LRIT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets